Publications by authors named "Muwen Lin"

Claim this Profile
C
Case report: Transformative potential of trastuzumab deruxtecan in the first line treatment for advanced HER2-mutated lung adenocarcinoma: a case report and clinical insights.
Guanbin Huang, Tongtong Xia, Dongxiao Yang, Muwen Lin, Yiping Luo, Hualin Chen

Front Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Hua-Lin Chen, Yi-Ping Luo, Mu-Wen Lin, Xiao-Xia Peng, Mei-Liang Liu

Cancer Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC.
Shujun Li, Yanming Lin, Yanxia Wu, Hualin Chen, Zhong Huang, Muwen Lin

J Healthc Eng· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and pathological characteristics of 11 NSCLC patients with c-MET exon 14 skipping.
Hualin Chen, Yipin Luo, Muwen Lin, Huoguang Chen, Meilian Liu

Transl Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis